ロード中...
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia
PURPOSE: The decision to re-induce patients with acute myeloid leukemia (AML) based on results of the day 14 bone marrow (BM) biopsy is variable and lacks evidence based data. The aim of our review was to evaluate the accuracy of a day 14 BM biopsy in determining the need for re-induction chemothera...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3753071/ https://ncbi.nlm.nih.gov/pubmed/23046833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.09.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|